OBJECTIVE: High survival rates have led to an increased emphasis on the functional outcomes of children diagnosed with low-grade glioma. Most outcomes research has focused on risks associated with radiotherapy, but less is known about neuropsychological risks for patients treated with surgery alone. Here, the authors sought to examine the neuropsychological trajectories of children diagnosed with a low-grade glioma and monitored up to 6 years postsurgery. Secondarily, they explored demographic and clinical predictors of neuropsychological performance. METHODS: The neuropsychological functioning of 32 patients (median age at diagnosis 10.0 years) was prospectively assessed annually for up to 6 years after surgery (median days from surgery at baseline = 72). Tumor location was predominately supratentorial (65.6%). A combination of performance-based and parent-reported measures was used to assess intelligence, memory, executive functioning, and fine motor control in all patients. RESULTS: Binomial tests at the postoperative baseline revealed that the proportion of children falling below the average range (< 16th percentile) was significantly higher than the rate expected among healthy peers on measures of verbal memory, processing speed, executive functioning, and fine motor control (p < 0.05). Even so, linear mixed models indicated that neuropsychological functioning at the postoperative baseline did not significantly change over time for up to 6 years after surgery across all domains. A larger tumor size was associated with a slower reaction time (p < 0.01). A supratentorial tumor location and history of seizures were associated with more parent-reported executive difficulties (p < 0.01). CONCLUSIONS: While radiotherapy is a known risk factor for neuropsychological deficits in pediatric brain tumor patients, findings in this study indicate that children treated for low-grade glioma with surgery alone (without radiotherapy or chemotherapy) remain susceptible to difficulties with memory, executive functioning, and motor functioning that persist over time. Over half of the children in the study sample required school support services to address neuropsychological weaknesses. Although low-grade glioma is often conceptualized as a benign tumor, children treated for this lesion require ongoing monitoring and intervention to address neuropsychological weaknesses resulting from the tumor itself as well as the surgery.
OBJECTIVE: High survival rates have led to an increased emphasis on the functional outcomes of children diagnosed with low-grade glioma. Most outcomes research has focused on risks associated with radiotherapy, but less is known about neuropsychological risks for patients treated with surgery alone. Here, the authors sought to examine the neuropsychological trajectories of children diagnosed with a low-grade glioma and monitored up to 6 years postsurgery. Secondarily, they explored demographic and clinical predictors of neuropsychological performance. METHODS: The neuropsychological functioning of 32 patients (median age at diagnosis 10.0 years) was prospectively assessed annually for up to 6 years after surgery (median days from surgery at baseline = 72). Tumor location was predominately supratentorial (65.6%). A combination of performance-based and parent-reported measures was used to assess intelligence, memory, executive functioning, and fine motor control in all patients. RESULTS: Binomial tests at the postoperative baseline revealed that the proportion of children falling below the average range (< 16th percentile) was significantly higher than the rate expected among healthy peers on measures of verbal memory, processing speed, executive functioning, and fine motor control (p < 0.05). Even so, linear mixed models indicated that neuropsychological functioning at the postoperative baseline did not significantly change over time for up to 6 years after surgery across all domains. A larger tumor size was associated with a slower reaction time (p < 0.01). A supratentorial tumor location and history of seizures were associated with more parent-reported executive difficulties (p < 0.01). CONCLUSIONS: While radiotherapy is a known risk factor for neuropsychological deficits in pediatric brain tumor patients, findings in this study indicate that children treated for low-grade glioma with surgery alone (without radiotherapy or chemotherapy) remain susceptible to difficulties with memory, executive functioning, and motor functioning that persist over time. Over half of the children in the study sample required school support services to address neuropsychological weaknesses. Although low-grade glioma is often conceptualized as a benign tumor, children treated for this lesion require ongoing monitoring and intervention to address neuropsychological weaknesses resulting from the tumor itself as well as the surgery.
Entities:
Keywords:
BRIEF = Behavior Rating Inventory of Executive Function; CPT = Continuous Performance Test; D-KEFS = Delis-Kaplan Executive Function System; FSIQ = Full Scale IQ; LGG = low-grade glioma; PRI = Perceptual Reasoning Index; PSI = Processing Speed Index; VCI = Verbal Comprehension Index; WISC-V = Wechsler Intelligence Scale for Children, Fifth Edition; WMI = Working Memory Index; brain tumor; executive functioning; low-grade glioma; neuropsychology; oncology; pediatric; surgery only
Authors: Jeffrey H Wisoff; Robert A Sanford; Linda A Heier; Richard Sposto; Peter C Burger; Allan J Yates; Emiko J Holmes; Larry E Kun Journal: Neurosurgery Date: 2011-06 Impact factor: 4.654
Authors: Elisabeth M S Sherman; Samuel Wiebe; Taryn B Fay-McClymont; Jose Tellez-Zenteno; Amy Metcalfe; Lisbeth Hernandez-Ronquillo; Walter J Hader; Nathalie Jetté Journal: Epilepsia Date: 2011-03-22 Impact factor: 5.864
Authors: Dean W Beebe; M Douglas Ris; F Daniel Armstrong; John Fontanesi; Raymond Mulhern; Emi Holmes; Jeffrey H Wisoff Journal: J Clin Oncol Date: 2005-08-01 Impact factor: 44.544
Authors: Anthony LoGalbo; Stephen Sawrie; David L Roth; Ruben Kuzniecky; Robert Knowlton; Edward Faught; Roy Martin Journal: Epilepsy Behav Date: 2005-05 Impact factor: 2.937
Authors: Andu Turken; Susan Whitfield-Gabrieli; Roland Bammer; Juliana V Baldo; Nina F Dronkers; John D E Gabrieli Journal: Neuroimage Date: 2008-04-11 Impact factor: 6.556
Authors: M J Roman; D C Delis; L Willerman; M Magulac; T L Demadura; J L de la Peña; C Loftis; J Walsh; M Kracun Journal: J Clin Exp Neuropsychol Date: 1998-04 Impact factor: 2.475
Authors: M Douglas Ris; Dean W Beebe; F Daniel Armstrong; John Fontanesi; Emi Holmes; Robert A Sanford; Jeffrey H Wisoff Journal: J Clin Oncol Date: 2008-09-08 Impact factor: 44.544
Authors: Derek S Tsang; Laurence Kim; Zhihui Amy Liu; Laura Janzen; Mohammad Khandwala; Eric Bouffet; Normand Laperriere; Hitesh Dama; Dana Keilty; Tim Craig; Vijay Ramaswamy; David C Hodgson; Donald Mabbott Journal: Neuro Oncol Date: 2021-03-25 Impact factor: 12.300
Authors: Ade Oyefiade; Iris Paltin; Cinzia R De Luca; Kristina K Hardy; David R Grosshans; Murali Chintagumpala; Donald J Mabbott; Lisa S Kahalley Journal: J Clin Oncol Date: 2021-04-22 Impact factor: 50.717